Launchcode: AI, Pharma and the Next Frontier, Volume 2: The Commercial AI Playbook

Author:   Larry Mickelberg
Publisher:   Axonal.AI LLC
ISBN:  

9781968615024


Pages:   254
Publication Date:   29 July 2025
Format:   Paperback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $39.47 Quantity:  
Add to Cart

Share |

Launchcode: AI, Pharma and the Next Frontier, Volume 2: The Commercial AI Playbook


Overview

Volume 2: The Commercial AI Playbook reveals how AI agents are redefining the operating model of pharmaceutical commercialization. From omnichannel planning and brand strategy to insight generation and launch execution, Larry Mickelberg unpacks how agentic systems reinvent the daily workflows of modern commercial teams. This volume offers a practical blueprint for rebuilding the commercial stack-task by task, role by role-with intelligent agents at the core. For leaders of brand, field, and agency teams, it's a playbook for speed, adaptability, and competitive advantage in the era of AI-powered precision.

Full Product Details

Author:   Larry Mickelberg
Publisher:   Axonal.AI LLC
Imprint:   Axonal.AI LLC
Dimensions:   Width: 15.20cm , Height: 1.30cm , Length: 22.90cm
Weight:   0.345kg
ISBN:  

9781968615024


ISBN 10:   1968615024
Pages:   254
Publication Date:   29 July 2025
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Larry Mickelberg is the founder and CEO of Axonal.AI, a company pioneering the use of agentic AI systems to transform pharmaceutical commercialization. A recognized leader in healthcare marketing and digital transformation, Larry has held senior executive roles at global consultancies and agency networks, including Publicis Health, Deloitte, and Havas. With more than two decades of experience advising life sciences companies on strategy, innovation, and technology adoption, he has been at the forefront of helping organizations modernize how therapies are launched and scaled globally. Larry's work now centers on building intelligent, secure AI workspaces that enable pharmaceutical teams and their agencies to move faster from data to actionable insight - reshaping the commercial operating model for the AI era.

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

April RG 26_2

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List